Sarissa Capital Management as of Dec. 31, 2013
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 12 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ariad Pharmaceuticals | 30.6 | $82M | 12M | 6.82 | |
| Quest Diagnostics Incorporated (DGX) | 14.0 | $38M | 700k | 53.54 | |
| Idenix Pharmaceuticals | 11.3 | $30M | 5.1M | 5.98 | |
| Vivus | 8.8 | $23M | 2.6M | 9.08 | |
| Merck & Co (MRK) | 7.5 | $20M | 400k | 50.05 | |
| Mallinckrodt Pub SHS | 5.5 | $15M | 280k | 52.26 | |
| Bristol Myers Squibb (BMY) | 5.0 | $13M | 250k | 53.15 | |
| Abbvie (ABBV) | 4.9 | $13M | 250k | 52.81 | |
| Pfizer (PFE) | 4.7 | $13M | 410k | 30.63 | |
| Repros Therapeutics Com New | 3.1 | $8.4M | 460k | 18.30 | |
| Bio-reference Labs Com $.01 New | 2.7 | $7.3M | 285k | 25.54 | |
| AVEO Pharmaceuticals | 1.8 | $4.7M | 2.6M | 1.84 |
